RNA-specific assays are frequently used to monitor the reservoir activation. Because HIV 27 preferentially integrates into actively transcribed genes, some of the transcripts detected by 28 these assays may not represent genuine HIV RNA but chimeric host-HIV readthrough 29
transcripts. Here we demonstrate that in HIV-infected patients on suppressive cART, such 30 host-derived transcripts do not significantly contribute to the HIV gag RNA level. 31 32 Cell-associated (CA) HIV unspliced RNA is an important marker of the viral reservoir and the 33 response to combination antiretroviral therapy (cART) (1) . Recently, there has been considerable 34 interest in the utilization of CA HIV RNA as a surrogate marker of virus activation by latency-35 reversing agents (LRA) (2), and it has been used as a main output measure in several clinical trials 36 aimed at reduction of the HIV reservoir (3-6). Primers specific for the HIV gag region are frequently 37 used in PCR-based assays that quantify unspliced RNA (7,8). However, because HIV integrates 38 preferentially within actively transcribed host genes (Fig. 1A ) (9), it has been suggested that some of 39 the transcripts detected by the gag-specific assays may not represent genuine HIV RNA but rather 40 chimeric host-HIV readthrough transcripts that are transcribed from host promoters (10). In this 41
case, an effect of LRA measured by induction of gag RNA transcription could represent activation 42 of a host gene, instead of HIV latency reversal. Therefore, to properly interpret the results of the gag 43 assays, it is necessary to determine the relative contribution of such readthrough transcripts to the 44 total HIV gag RNA signal in cART-treated patients. 45
We developed a sensitive nested real-time PCR assay that amplifies the 5' long terminal 46 repeat (LTR)-encoded U3 -packaging signal region (U3-Psi) of HIV-1. As the forward primers are 47 located 5' of the HIV LTR transcription start site, this assay specifically detects host-HIV 48 readthrough transcripts but not genuine HIV-1 unspliced RNA (Fig. 1B) . The assay has a linear 49 range of five orders of magnitude and the sensitivity of four copies per reaction (Fig. 2) . For this 50 study, we used peripheral blood mononuclear cells (PBMC) of 48 cART-treated patients visiting the 51 HIV outpatient clinic of the Academic Medical Center in 2011-2013 and participating in the Co-52 morBidity in Relation to AIDS (COBRA) cohort, whose plasma viremia had been undetectable (<40 53 copies/ml) for a median of 7 years prior to the time of sampling. The median CD4 + T-cell count was 54 675.5 cells/mm 3 . Total DNA and total RNA were isolated from the patient PBMC using the Boom 55 isolation method (11) and CA HIV DNA and RNA were separately quantified using both the U3-Psi 56 assay and the seminested real-time PCR assay specific for the HIV gag region ( interfere with the quantitation, and reverse transcribed using random primers and Superscript III 59 reverse transcriptase (both Invitrogen). As HIV integrates in a random orientation with regard to the 60 host genes, we used random primers to allow detection of readthrough RNA transcribed in both 61 directions, from both upstream and downstream host promoters (Fig. 1A) . Same-volume aliquots of 62 the same DNA or cDNA preparations were used as input for U3-Psi and gag assays. HIV DNA and 63 RNA were normalized to the cellular inputs as described previously (12). 64
As expected, both U3-Psi and gag assays detected HIV DNA in >90% of the patients (44/48 65 and 46/48, respectively) with no significant quantitative bias between the assays (0.13±0.50 log 10 ; 66 P>0.05 for comparison of the difference to 0) (Fig. 3) , and a highly significant correlation between 67 the two measurements was observed (P=0.001), demonstrating the functionality of the U3-Psi assay. 68
However, a major difference in detectability of HIV RNA was observed. HIV gag RNA was 69 detected in 44/48 of these patients (92%) with a median copy number of 590 (interquartile range, 70 217-1194) copies/µg total RNA. However, the detectability of readthrough RNA was only 40% 71 (19/48 patients) (Fig. 4A) . In these 19 patients where the readthrough RNA was detected, its median 72 copy number was 49 (41-122) copies/µg total RNA (P=0.0001 for the paired comparison with the 73 HIV gag RNA) (Figs. 4B, 4C ). This represented only 8.3% (2.4%-11.2%) of the HIV gag RNA 74 (Fig. 4D) . Notably, this is a large overestimation and the real readthrough/gag RNA ratio is much 75 lower, as patients with undetectable readthrough RNA (60% of all patients) were excluded from this 76 
